📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Abstract PR04: DNA-PK inhibition resensitizes ovarian cancer cells to cisplatin in vivo and is associated with modulation of AKT pathway signaling (2013)

First Author: Cheraghchi-Bashi-Astaneh A

Attributed to: Confidence in Concept 2012 - Imperial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ovca13-pr04

Publication URI: http://dx.doi.org/10.1158/1078-0432.ovca13-pr04

Type: Journal Article/Review

Parent Publication: Clinical Cancer Research

Issue: 19_Supplement